cholera
The Rainy Season Doesn't Wait for the Exchange Rate - Disruption Risk Intelligence, Edition 8
Cholera, currencies and the countries that pay twice: Edition 8 of Disruption Risk Intelligence.
cholera
Cholera, currencies and the countries that pay twice: Edition 8 of Disruption Risk Intelligence.
finance and the medical supply chain
We are asking a narrow question: if the AI bubble bursts, how are health supply chains impacted?
critical care equipment supply chain vulnerability
The quietest Atlantic hurricane season of the satellite era still produced a Category 3 storm. Isaias missed the Gulf Coast resin corridor, but hit while refining had little headroom. Which buffers stand between a Gulf storm and a hospital shelf, and where do they run thin?
critical care equipment supply chain vulnerability
The global medical glove market is in surplus, yet health workers fighting Ebola in DRC ran short of gloves and PPE. Edition 5 examines nitrile glove supply chains, US tariffs, trade flows, and last-mile logistics, and why commodity data missed the frontline gap.
Cross-Sector Disruption Intelligence
Medical grade oxygen is a critical to essential therapeutic care. Biomedical equipment for oxygen treatment is highly dependent on components that are other industries use. This Edition discusses how these other sectors have and could potentially impact access to oxygen.
Cross-Sector Disruption Intelligence
Rhine drought disrupts Rotterdam-to-Germany chemical logistics. Verolyx tracks the exposure pathways into pharma supply chains, and where the risk is, and isn't.
Cross-Sector Disruption Intelligence
Polypropylene is under active price and logistics disruption from the March 2026 Iran conflict and Strait of Hormuz feedstock shock — a cost story, not a shortage, reaching automotive, packaging, and medical/PPE buyers alike.
Global Health Security
Cross-Sector Disruption Intelligence Heparin Disruption Risk Intelligence — Edition 1 July 2026 1 AT A GLANCE Critical Heparin is a widely used anti-coagulant essential to cardiovascular surgery, dialysis, and clot prevention, making it a critical care drug with no easy substitute at scale. Demand is driven by rising surgical